Clinical features of drug-induced Parkinsonism

被引:5
|
作者
Shiraiwa, Nobuko [1 ]
Tamaoka, Akira [2 ]
Ohkoshi, Norio [1 ]
机构
[1] Tsukuba Univ Technol, Dept Hlth Sci, Course Neurol, Tsukuba, Ibaraki, Japan
[2] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Neurol, Tsukuba, Ibaraki, Japan
关键词
Drug-induced Parkinsonism; sulpiride; Parkinson's disease; malignant syndrome; oromandibular dyskinesia;
D O I
10.4081/ni.2018.7877
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several factors, including age, sex, causative drug and reason for prescription, department by which it was prescribed, and outcome. The age at onset ranged from 40 to 87 years, with an average Hoehn and Yahr Scale score of 4, indicating severe disability. Sulpiride was the most commonly observed causative drug (71.4%). All causative drugs were prescribed in non-neurological departments and over one half were prescribed in non-psychiatric departments; most were prescribed to treat depression or abdominal discomfort. Ten patients (48%) were previously diagnosed with a neuromuscular disease, including cerebrovascular diseases and Parkinson's disease. Recovery was observed in 15 cases (71%) after withdrawal of the causative drug, but lingering symptoms were observed in the remaining cases. It is suggested that physicians should be more cautious of Parkinsonian side effects when prescribing such drugs.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 50 条
  • [31] Drug-induced Parkinsonism in Taiwan
    Lin, J. -J.
    Yueh, K. -C.
    Chen, A. -C.
    MOVEMENT DISORDERS, 2016, 31 : S292 - S292
  • [32] Drug-induced parkinsonism in the elderly
    Chou, Kelvin L.
    Friedman, Joseph H.
    FUTURE NEUROLOGY, 2007, 2 (03) : 307 - 316
  • [33] DRUG-INDUCED EXPERIMENTAL PARKINSONISM
    MORRISON, AB
    WEBSTER, RA
    NEUROPHARMACOLOGY, 1973, 12 (08) : 715 - 724
  • [34] SUSCEPTIBILITY TO DRUG-INDUCED PARKINSONISM
    RAJPUT, AH
    ROZDILSKY, B
    HORNYKIEWICZ, O
    SHANNAK, K
    LEE, T
    SEEMAN, P
    NEUROLOGY, 1979, 29 (04) : 567 - 567
  • [35] Drug-induced parkinsonism with amiodarone
    Erdem, N. F.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S164 - S164
  • [36] Clinical and MRI-characteristics of drug-induced Parkinsonism in Uzbekistan
    Umarov, A.
    Prokhorova, A.
    Rakhimbaeva, G.
    Mirzaeva, K.
    Tuychibaeva, N.
    MOVEMENT DISORDERS, 2016, 31 : S289 - S290
  • [37] Drug-induced parkinsonism: Prevalence, clinical features and follow-up study in three Sicilian communities
    Morgante, L
    DiRosa, AE
    Savettieri, G
    Reggio, A
    Patti, F
    Salemi, G
    DiLorenzo, G
    Epifanio, A
    DiPerri, R
    JOURNAL OF NEUROLOGY, 1996, 243 (03) : 293 - 295
  • [38] UNSUSPECTED, SURREPTITIOUS DRUG-INDUCED PARKINSONISM
    ALBANESE, A
    COLOSIMO, C
    BENTIVOGLIO, AR
    BERGONZI, P
    NEUROLOGY, 1992, 42 (02) : 459 - 459
  • [39] DRUG-INDUCED PARKINSONISM - A GROWING LIST
    MASSO, JFM
    CARRERA, N
    URTASUN, M
    MOVEMENT DISORDERS, 1993, 8 (01) : 125 - 125
  • [40] DRUG-INDUCED PARKINSONISM AND SEBORRHEIC DERMATITIS
    不详
    PHARMACY INTERNATIONAL, 1983, 4 (10): : 256 - 256